Coral Laboratories Q2 Results
- BSE: 524506
- NSE: -
- ISIN: INE683E01017
- Sector: Biotechnology & Drugs
BSE
436.00
6.90 (1.61%)
6.90 (1.61%)Volume1.46 K
Updated: Fri 6 Mar, 2026 | 15:12:24
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Coral Laboratories Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 14.23 | 17.09 | -16.77% | 26.23 | -45.77% |
| Depreciation/ Amortization | 0.45 | 0.45 | -0.22% | 0.51 | -11.16% |
| Operating Income | 4.81 | 1.73 | 178.12% | 6.00 | -19.82% |
| Net Income | 5.82 | 2.56 | 126.97% | 6.38 | -8.77% |
| Other Operating Expenses Total | 2.85 | 4.48 | -36.48% | 6.24 | -54.38% |
| Net Income Before Taxes | 7.42 | 3.72 | 99.37% | 8.53 | -13.07% |
| Total Revenue | 19.03 | 18.82 | 1.13% | 32.23 | -40.94% |
| Selling/ General/ Admin Expenses Total | 3.70 | 3.42 | 8.13% | 3.93 | -5.90% |
| Diluted Normalized EPS | 15.58 | 7.18 | 117.01% | 17.86 | -12.76% |